Moderna and Vertex Pharmaceuticals are now holdings in the GNOM ETF.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna and Vertex Pharmaceuticals are now holdings in the GNOM ETF.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Moderna
American biotechnology company
-
Vertex Pharmaceuticals
American pharmaceutical company
Related events
- Direct financial comparison of two market rivals: Vertex Pharmaceuticals and Prothena Corporation plc.
- Vertex Pharmaceuticals trades on Nasdaq, files reports with the SEC, and has an executive named Duncan McKechnie.
- Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.
- Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.
- Vertex Pharmaceuticals CEO leads the company's strategic business direction.